Linked Life Data

3909841

Source:http://linkedlifedata.com/resource/pubmed/id/3909841

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1986-1-24
pubmed:abstractText
Physostigmine is an approved antidote in the treatment of intoxication as well as in the management of overdoses of numerous medications--many of which are used in the course of pre-medication or anesthesia induction or maintenance. In order to clarify whether or not physostigmine can accelerate the restoration of normal vigilance, a randomised, double-blind study of 60 patients was performed on the basis of 14 pre-determined vigilance criteria. The patients who received physostigmine demonstrated a significantly superior and more rapid restoration of consciousness as compared to the control group. Side-effects following administration were not observed. The results of our study indicate that post-anaesthesia administration of physostigmine appears useful in the treatment of certain types of patients.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0003-2417
pubmed:author
pubmed:issnType
Print
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
456-61
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1985
pubmed:articleTitle
[Modification of vigilance in the postanesthetic phase using physostigmine].
pubmed:publicationType
Journal Article, Clinical Trial, English Abstract, Randomized Controlled Trial